Condition: Ovarian Cancer · Sponsor: Canadian Cancer Trials Group
This study is being done to answer the following question: What are the effects of a new drug or drugs on ovarian cancer? The pre-study screening may be done to test a sample of tissue for biomarkers to determine participation in the study.
This description comes directly from the study's public registry record.
Janet Dancey · 613-533-6430 · jdancey@ctg.queensu.ca
Pierre-Olivier Gaudreau · 613-533-6430 · p-ogaudreau@ctg.queensu.ca
Always discuss trial participation with your own doctor first.
| The University of Chicago Medical Center | Chicago, Illinois, United States | Recruiting |
| BCCA - Kelowna | Kelowna, British Columbia, Canada | Not Yet Recruiting |
| BCCA - Vancouver | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| Odette Cancer Centre | Toronto, Ontario, Canada | Not Yet Recruiting |
| University Health Network | Toronto, Ontario, Canada | Not Yet Recruiting |
| CHUM-Centre Hospitalier de l'Universite de Montreal | Montreal, Quebec, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04918186